title: Comparisons of resistance of CF and non-CF pathogens to hydrogen peroxide and hypochlorous acid oxidants in vitro.
abstract: BACKGROUND
  Cystic fibrosis (CF) lung disease has a unique profile of pathogens predominated by Pseudomonas aeruginosa (PsA) and Staphylococcus aureus (SA). These microorganisms must overcome host immune defense to colonize the CF lungs. Polymorphonuclear neutrophils are a major component of the host defense against bacterial infection. A crucial microbicidal mechanism is the production of oxidants including hydrogen peroxide (H2O2) and hypochlorous acid (HOCl) by neutrophils to achieve efficient bacterial killing. To determine to what degrees various CF pathogens resist the oxidants relative to non-CF pathogens, we compared the susceptibility of PsA, SA, Burkholderia cepacia (BC), Klebsiella pneumoniae (KP), and Escherichia coli (EC) to various concentrations of H2O2 or HOCl, in vitro. The comparative oxidant-resistant profiles were established. Oxidant-induced damage to ATP production and cell membrane integrity of the microbes were quantitatively assessed. Correlation of membrane permeability and ATP levels with bacterial viability was statistically evaluated.
  
  
  RESULTS
  PsA was relatively resistant to both H2O2 (LD50 = 1.5 mM) and HOCl (LD50 = 0.035 mM). SA was susceptible to H2O2 (LD50 = 0.1 mM) but resistant to HOCl (LD50 = 0.035 mM). Interestingly, KP was extremely resistant to high doses of H2O2 (LD50 = 2.5-5.0 mM) but was very sensitive to low doses of HOCl (LD50 = 0.015 mM). BC was intermediate to resist both oxidants: H2O2 (LD50 = 0.3-0.4 mM) and HOCl (LD50 = 0.025 mM). EC displayed the least resistance to H2O2 (LD50 = 0.2-0.3 mM) and HOCl (LD50 = 0.015 mM). The identified profile of H2O2-resistance was KP > PsA > BC > EC > SA and the profile of HOCl-resistance PsA > SA > BC > EC > KP. Moreover, both oxidants affected ATP production and membrane integrity of the cells. However, the effects varied among the tested organisms and, the oxidant-mediated damage correlated differentially with the bacterial viability.
  
  
  CONCLUSIONS
  The order of HOCl-resistance identified herein best fits the clinical profile of CF infections. Even though oxidants are able to disrupt ATP production and cell membrane integrity, the degrees of damage vary among the organisms and correlate differentially with their viability.
authors: Department of Genetics, Louisiana State University Health Sciences Center New Orleans, LA 70112, USA.
authors: Ryan W
authors: RW
authors: Bonvillain
authors: Richard G
authors: RG
authors: Painter
authors: Elisa M
authors: EM
authors: Ledet
authors: Guoshun
authors: G
authors: Wang
references: J Leukoc Biol. 2005 May;77(5):598-625
references: 15689384
references: Am J Respir Crit Care Med. 1996 Nov;154(5):1229-56
references: 8912731
references: Biochemistry. 2006 Aug 29;45(34):10260-9
references: 16922501
references: Biochem J. 1988 Sep 15;254(3):685-92
references: 2848494
references: Am J Respir Crit Care Med. 1999 Jul;160(1):186-91
references: 10390398
references: Immunol Rev. 2007 Oct;219:88-102
references: 17850484
references: J Biol Chem. 2006 Dec 29;281(52):39860-9
references: 17074761
references: J Immunol. 2008 Jan 1;180(1):500-9
references: 18097052
references: J Clin Microbiol. 2003 Sep;41(9):4424-7
references: 12958283
references: Infect Immun. 1996 Sep;64(9):3512-7
references: 8751892
references: Biochem Biophys Res Commun. 1995 Jul 26;212(3):868-74
references: 7626123
references: Experientia. 1996 Feb 15;52(2):167-74
references: 8608819
references: J Clin Invest. 1986 Jul;78(1):177-84
references: 3013936
references: J Leukoc Biol. 2010 May;87(5):933-42
references: 20089668
references: Infect Immun. 1981 Jan;31(1):11-6
references: 6260658
references: Clin Infect Dis. 1998 Jul;27(1):158-63
references: 9675470
references: Pediatr Pulmonol. 1996 May;21(5):267-75
references: 8726151
references: J Immunol. 2009 Aug 15;183(4):2632-41
references: 19620311
references: Biochemistry. 1989 Nov 14;28(23):9172-8
references: 2557918
references: Am J Respir Crit Care Med. 2005 Jun 1;171(11):1209-23
references: 15695491
references: J Infect Dis. 2001 Feb 1;183(3):444-52
references: 11133376
references: J Leukoc Biol. 2008 Jun;83(6):1345-53
references: 18353929
references: Pediatr Pulmonol. 2001 Nov;32(5):356-66
references: 11596160
references: Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51
references: 14555458
references: Science. 1992 May 8;256(5058):774-9
references: 1375392
references: J Bacteriol. 1988 Aug;170(8):3655-9
references: 3136145
references: Annu Rev Microbiol. 2003;57:677-701
references: 14527295